SG11201600754PA - Compositions and methods for multimodal analysis of cmet nucleic acids - Google Patents

Compositions and methods for multimodal analysis of cmet nucleic acids

Info

Publication number
SG11201600754PA
SG11201600754PA SG11201600754PA SG11201600754PA SG11201600754PA SG 11201600754P A SG11201600754P A SG 11201600754PA SG 11201600754P A SG11201600754P A SG 11201600754PA SG 11201600754P A SG11201600754P A SG 11201600754PA SG 11201600754P A SG11201600754P A SG 11201600754PA
Authority
SG
Singapore
Prior art keywords
cmet
compositions
methods
nucleic acids
multimodal analysis
Prior art date
Application number
SG11201600754PA
Other languages
English (en)
Inventor
Jork Nolling
Kiran Madanahally Divakar
Original Assignee
Qiagen Mansfield Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qiagen Mansfield Inc filed Critical Qiagen Mansfield Inc
Publication of SG11201600754PA publication Critical patent/SG11201600754PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00Reactions demanding special reaction conditions
    • C12Q2527/143Concentration of primer or probe
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201600754PA 2013-08-14 2014-08-07 Compositions and methods for multimodal analysis of cmet nucleic acids SG11201600754PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361865755P 2013-08-14 2013-08-14
PCT/US2014/050076 WO2015023503A2 (en) 2013-08-14 2014-08-07 Compositions and methods for multimodal analysis of cmet nucleic acids

Publications (1)

Publication Number Publication Date
SG11201600754PA true SG11201600754PA (en) 2016-02-26

Family

ID=51358135

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201600754PA SG11201600754PA (en) 2013-08-14 2014-08-07 Compositions and methods for multimodal analysis of cmet nucleic acids

Country Status (9)

Country Link
US (1) US20160130660A1 (enExample)
EP (1) EP3033434A2 (enExample)
JP (1) JP2016527900A (enExample)
KR (1) KR20160106040A (enExample)
CN (1) CN105745335A (enExample)
BR (1) BR112016003057A2 (enExample)
CA (1) CA2917924A1 (enExample)
SG (1) SG11201600754PA (enExample)
WO (1) WO2015023503A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017006216A (es) 2014-11-14 2018-08-29 Voyager Therapeutics Inc Composiciones y métodos para tratar la esclerosis lateral amiotrófica (ela).
WO2018025856A1 (ja) * 2016-08-02 2018-02-08 学校法人武庫川学院 簡便な遺伝子検査法およびコピー数計測法ならびにその支援技術
AU2018261790B2 (en) 2017-05-05 2024-10-03 Voyager Therapeutics, Inc. Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
US11434502B2 (en) 2017-10-16 2022-09-06 Voyager Therapeutics, Inc. Treatment of amyotrophic lateral sclerosis (ALS)
CN108893536B (zh) * 2018-07-13 2022-02-15 江苏省人民医院(南京医科大学第一附属医院) 一种从人外周血CTC中检测c-MET基因拷贝数变异的方法和试剂盒
US20210324461A1 (en) * 2018-08-16 2021-10-21 Life Technologies Corporation Reagents, mixtures, kits and methods for amplification of nucleic acids
KR20210107492A (ko) * 2020-02-24 2021-09-01 (재)록원바이오융합연구재단 복제수 변이 검출용 표준화 유전자의 선별 방법 및 상기 방법에 의해서 선별된 c-Met 복제수 변이 검출용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3756313B2 (ja) 1997-03-07 2006-03-15 武 今西 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
US7445893B2 (en) 2002-04-12 2008-11-04 Primera Biosystems, Inc. Sampling method for amplification reaction analysis
US20070213292A1 (en) 2005-08-10 2007-09-13 The Rockefeller University Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
EP2543742A1 (en) 2007-11-07 2013-01-09 Primeradx, Inc. Quantification of nucleic acid molecules using multiplex PCR
EP2143441A1 (en) * 2008-07-08 2010-01-13 Pierre Fabre Medicament Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer
PA8849001A1 (es) * 2008-11-21 2010-06-28 Lilly Co Eli Anticuerpos de c-met
CA2748265C (en) * 2008-12-22 2018-04-03 University Of Utah Research Foundation Monochrome multiplex quantitative pcr
EP2656077A1 (en) * 2010-12-23 2013-10-30 Nestec S.A. Drug selection for malignant cancer therapy using antibody-based arrays
ES2734673T3 (es) * 2011-03-02 2019-12-11 Nestle Sa Predicción de la sensibilidad farmacológica de tumores de pulmón basándose en identificaciones moleculares y genéticas

Also Published As

Publication number Publication date
KR20160106040A (ko) 2016-09-09
CN105745335A (zh) 2016-07-06
US20160130660A1 (en) 2016-05-12
JP2016527900A (ja) 2016-09-15
WO2015023503A3 (en) 2015-07-16
CA2917924A1 (en) 2015-02-19
EP3033434A2 (en) 2016-06-22
BR112016003057A2 (pt) 2017-11-21
WO2015023503A2 (en) 2015-02-19

Similar Documents

Publication Publication Date Title
IL280155A (en) Anti- SIGLEC-8 antibodies and methods of using them
ZA201507006B (en) Compositions and methods of nucleic acid-targeting nucleic acids
IL245909A0 (en) Libraries of nucleic acids and methods for their preparation
EP2994543A4 (en) Device for preparation and analysis of nucleic acids
GB2522298B (en) Opto-physiological sensor and method of assembly
IL244495A0 (en) Anti-alpha-synuclein antibodies and methods of use
SG10201707485YA (en) Methods and devices for analysis of defined multicellular combinations
LT3086807T (lt) Antikūnai ir jų naudojimo būdai
EP2992083A4 (en) Analysis of dna
SG11201600754PA (en) Compositions and methods for multimodal analysis of cmet nucleic acids
PL3071969T3 (pl) Sposób analizy
IL244033B (en) Methods and preparations for the extraction and storage of nucleic acids
IL241290A0 (en) Subprevir polymorphs and methods for their production
ZA201600927B (en) Structural assembly and method of assembly thereof
GB201323015D0 (en) Kits and methods for analysis of DNA
IL240734A0 (en) Methods and compositions for preparing nucleic acids
EP2948751A4 (en) METHOD AND DEVICE FOR THE ANALYSIS OF FATTY ACIDS
EP3047037A4 (en) Compositions and methods for the analysis of radiosensitivity
ZA201602304B (en) Modified anti-inflammatory proteins and method of use
GB201323123D0 (en) Method for the preparation of biopolymers
TWM475581U (en) Analysis system of behavior
GB201307666D0 (en) Methods and compositions for identifying nucleic acids
GB201307665D0 (en) Methods and compositions for identifying nucleic acids
GB201307663D0 (en) Methods and compositions for identifying nucleic acids
GB201307664D0 (en) Methods and compostions for identifying nucleic acids